Dynamic activation of the key pathways: Linking colitis to colorectal cancer in a mouse model

Carcinogenesis

Volumn 33, Issue 7, 2012, Pages 1375-1383

  Tang, Anliu ^a,b   Li, Nan ^a,b   Li, Xiayu ^a,b   Yang, Hongyuan ^a,b,d   Wang, Wei ^a,b   Zhang, Liyang ^c   Li, Guiyuan ^b,c   Xiong, Wei ^b,c   Ma, Jian ^b,c   Shen, Shourong ^a,b  

^a THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d WEIFANG PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; STAT3 PROTEIN; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; COLITIS; COLITIS ASSOCIATED CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION PROFILING; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANIMALS; COLITIS; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MAP KINASE SIGNALING SYSTEM; MICE; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84865188305     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs183     Document Type: Article

References (43)

1. Coussens,L.M. et al. (2002) Inflammation and cancer. Nature, 420, 860-867.
2. Nathan,C. et al. (2010) Nonresolving inflammation. Cell, 140, 871-882.
3. Zisman,T.L. et al. (2008) Colorectal cancer and dysplasia in inflammatory bowel disease. World J. Gastroenterol., 14, 2662-2669.
4. Karin,M. (2006) Nuclear factor-kappa B in cancer development and progression. Nature, 441, 431-436.
5. Xiao,H. et al. (2007) The toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity, 26, 461-475.
6. Popivanova,B.K. et al. (2008) Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J. Clin. Invest., 118, 560-570.
7. Grivennikov,S. et al. (2009) IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell, 15, 103-113.
8. Hanahan,D. et al. (2011) Hallmarks of cancer: the next generation. Cell, 144, 646-674.
9. Subramanian,A. et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA, 102, 15545-15550.
10. Merico,D. et al. (2010) Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One, 5, e13984.
11. Smoot,M.E. et al. (2011) Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics, 27, 431-432.
12. Boivin,G.P. et al. (2003) Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology, 124, 762-777.
13. Lo,H.W. et al. (2010) Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes. Mol. Cancer Res., 8, 232-245.
14. Ray,S. et al. (2007) Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat. Med., 13, 1359-1362.
15. Cooper,H.S. et al. (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest., 69, 238-249.
16. Wood,L.D. et al. (1995) Constitutive and cytokine-induced expression of the melanoma growth stimulatory activity/GRO alpha gene requires both NF-kappa B and novel constitutive factors. J. Biol. Chem., 270, 30619-30626.
17. Hiscott,J. et al. (1993) Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol. Cell Biol., 13, 6231-6240.
18. Son,Y.H. et al. (2008) Roles of MAPK and NF-kappaB in interleukin-6 induction by lipopolysaccharide in vascular smooth muscle cells. J. Cardiovasc. Pharmacol., 51, 71-77.
19. Nishizawa,M. et al. (1990) Regulatory elements responsible for inducible expression of the granulocyte colony-stimulating factor gene in macrophages. Mol. Cell Biol., 10, 2002-2011.
20. Xia,Y.F. et al. (2001) NF-kappaB activation for constitutive expression of VCAM-1 and ICAM-1 on B lymphocytes and plasma cells. Biochem. Biophys. Res. Commun., 289, 851-856.
21. Thornburg,N.J. et al. (2007) Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/ Bcl-3 complexes. J. Virol., 81, 12954-12961.
22. Nemeth,J. et al. (2009) S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. Hepatology, 50, 1251-1262.
23. Tai,Y.T. et al. (2003) CD40 induces human multiple myeloma cell migration via phosphatidylinositol 3-kinase/AKT/NF-kappa B signaling. Blood, 101, 2762-2769.
24. Cai,S. et al. (2010) CXCL1 regulates pulmonary host defense to Klebsiella infection via CXCL2, CXCL5, NF-kappaB, and MAPKs. J. Immunol., 185, 6214-6225.
25. Bachmeier,B.E. et al. (2008) Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFkappaB. Carcinogenesis, 29, 779-789.
26. Richmond,A. (2002) NF-kappa B, chemokine gene transcription and tumour growth. Nat. Rev. Immunol., 2, 664-674.
27. Huber,M.A. et al. (2002) The IKK-2/I kappa B alpha/NF-kappa B pathway plays a key role in the regulation of CCR3 and eotaxin-1 in fibroblasts - A critical link to dermatitis in I kappa B alpha-deficient mice. J. Biol. Chem., 277, 1268-1275.
28. Brown,A. et al. (2008) The GM-CSF receptor utilises members of the canonical Wnt-signaling pathway during macrophage differentiation. Blood, 112, 1313.
29. Kuwabara,M. et al. (2007) Granulocyte colony-stimulating factor activates Wnt signal to sustain gap junction function through recruitment of beta-catenin and cadherin. FEBS Lett., 581, 4821-4830.
30. Tamura,M. et al. (2011) Regulation of CXCL12 expression by canonical Wnt signaling in bone marrow stromal cells. Int. J. Biochem. Cell Biol., 43, 760-767.
31. Oyegunwa,A.O. et al. (2010) Tetra-O-methyl nordihydroguaiaretic acid (Terameprocol) inhibits the NF-kappaB-dependent transcription of TNF-alpha and MCP-1/CCL2 genes by preventing RelA from binding its cognate sites on DNA. J. Inflamm. (Lond.), 7, 59.
32. Lutgens,M.W. et al. (2008) High frequency of early colorectal cancer in inflammatory bowel disease. Gut, 57, 1246-1251.
33. Greten,F.R. et al. (2004) IKK beta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell, 118, 285-296.
34. Kaur,S. et al. (2010) Propionibacterium acnes induces an inflammatory response in keratinocytes via crosstalk of the p38 MAPK and NF-kappa B pathways. J. Invest. Dermatol., 130, S123.
35. Cheng,W.L. et al. (2011) Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer. Ann. Oncol., 22, 2267-2276.
36. Begley,L.A. et al. (2008) CXCL5 promotes prostate cancer progression. Neoplasia, 10, 244-254.
37. Lin,W.W. et al. (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest., 117, 1175-1183.
38. Karin,M. et al. (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol., 5, 749-759.
39. Stephanou,A. et al. (2000) Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters. Cell Death Differ., 7, 329-330.
40. Wang,D. et al. (2010) The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene, 29, 781-788.
41. Jarnicki,A. et al. (2010) Stat3: linking inflammation to epithelial cancer -more than a "gut" feeling? Cell Div., 5, 14.
42. Yu,X. et al. (2010) Wnt/beta-catenin activation promotes prostate tumor progression in a mouse model. Oncogene, 30, 1868-1879.
43. Koskensalo,S. et al. (2011) MMP-7 as a prognostic marker in colorectal cancer. Tumour Biol., 32, 259-264.